Michelle Seltenrich

Michelle Seltenrich is an accomplished professional with extensive experience in corporate development and operations within the biopharmaceutical sector. Currently serving as Director of Corporate Development at Rakovina Therapeutics, Michelle focuses on enhancing awareness of the company's pipeline and technology. Previous roles include Director of FP&A at Zymeworks Inc. and Vice President of Operations at Sirona Biochem Corp., where Michelle was instrumental in negotiating significant licensing deals. Expertise spans from managing operational processes and budgets to overseeing corporate development efforts at Forbes Medi-Tech Inc. and establishing laboratory management at the University of British Columbia. Michelle holds a Master's degree in Business Administration and a Graduate Diploma in Business Administration from Simon Fraser University, as well as a Bachelor of Science in Biology from The University of British Columbia.